These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23724048)

  • 1. Has the rate of CD4 cell count decline before initiation of antiretroviral therapy changed over the course of the Dutch HIV epidemic among MSM?
    Gras L; Geskus RB; Jurriaans S; Bakker M; van Sighem A; Bezemer D; Fraser C; Prins JM; Berkhout B; de Wolf F;
    PLoS One; 2013; 8(5):e64437. PubMed ID: 23724048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007.
    Crum-Cianflone N; Eberly L; Zhang Y; Ganesan A; Weintrob A; Marconi V; Barthel RV; Fraser S; Agan BK; Wegner S
    Clin Infect Dis; 2009 May; 48(9):1285-92. PubMed ID: 19309306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
    Pantazis N; Morrison C; Amornkul PN; Lewden C; Salata RA; Minga A; Chipato T; Jaffe H; Lakhi S; Karita E; Porter K; Meyer L; Touloumi G;
    PLoS One; 2012; 7(3):e32369. PubMed ID: 22412867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How soon after HIV seroconversion is antiretroviral therapy initiated? The UK Register of HIV Seroconverters Steering Committee.
    AIDS; 1999 Jul; 13(10):1241-7. PubMed ID: 10416529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population-based survey data.
    Glaubius R; Kothegal N; Birhanu S; Jonnalagadda S; Mahiane SG; Johnson LF; Brown T; Stover J; Mangal TD; Pantazis N; Eaton JW
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25784. PubMed ID: 34546644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore.
    Ng OT; Lin L; Laeyendecker O; Quinn TC; Sun YJ; Lee CC; Leo YS
    PLoS One; 2011 Jan; 6(1):e15738. PubMed ID: 21298051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
    Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
    Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
    AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy.
    Wei L; Li H; Lv X; Zheng C; Li G; Yang Z; Chen L; Han X; Zou H; Gao Y; Cheng J; Wang H; Zhao J
    Retrovirology; 2021 Aug; 18(1):22. PubMed ID: 34399785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil.
    Djomand G; Duerr A; Faulhaber JC; Struchiner CJ; Pacheco AG; Barroso PF; Melo MF; Schechter M
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):401-4. PubMed ID: 17031316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do gender differences in CD4 cell counts matter?
    Prins M; Robertson JR; Brettle RP; Aguado IH; Broers B; Boufassa F; Goldberg DJ; Zangerle R; Coutinho RA; van den Hoek A
    AIDS; 1999 Dec; 13(17):2361-4. PubMed ID: 10597777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands.
    Gras L; Jurriaans S; Bakker M; van Sighem A; Bezemer D; Fraser C; Lange J; Prins JM; Berkhout B; de Wolf F;
    PLoS One; 2009 Oct; 4(10):e7365. PubMed ID: 19809510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection.
    Thornhill J; Inshaw J; Kaleebu P; Cooper D; Ramjee G; Schechter M; Tambussi G; Fox J; Samuel M; Miro JM; Weber J; Porter K; Fidler S
    J Acquir Immune Defic Syndr; 2016 Sep; 73(1):69-73. PubMed ID: 27070122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.
    Helleberg M; Kronborg G; Larsen CS; Pedersen G; Pedersen C; Obel N; Gerstoft J
    HIV Med; 2013 Jul; 14(6):362-9. PubMed ID: 23433434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort.
    Fidler S; Fox J; Touloumi G; Pantazis N; Porter K; Babiker A; Weber J
    AIDS; 2007 Jun; 21(10):1283-91. PubMed ID: 17545704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts.
    Huang X; Lodi S; Fox Z; Li W; Phillips A; Porter K; Lutsar I; Kelleher A; Li N; Xu X; Wu H; Johnson AM; ;
    J Acquir Immune Defic Syndr; 2013 Apr; 62(4):441-6. PubMed ID: 23221982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing linear CD4 decline quantifying diagnosis delay after HIV seroconversion: assessing the linearity assumption of CD4 decline.
    Robertson MM; Braunstein SL; Hoover DR; Li S; Nash D
    Ann Epidemiol; 2020 Dec; 52():1-6. PubMed ID: 32791198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines.
    Lodi S; Phillips A; Touloumi G; Geskus R; Meyer L; Thiébaut R; Pantazis N; Amo JD; Johnson AM; Babiker A; Porter K;
    Clin Infect Dis; 2011 Oct; 53(8):817-25. PubMed ID: 21921225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials.
    Buchacz K; Hu DJ; Vanichseni S; Mock PA; Chaowanachan T; Srisuwanvilai LO; Gvetadze R; Van Griensven F; Tappero JW; Kitayaporn D; Kaewkungwal J; Choopanya K; Mastro TD
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):853-60. PubMed ID: 15213570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.